Kubota Pharmaceutical Holdings Co., Ltd.

2026/11/06 19:48 Updated
Market Cap: $53.3M (¥8.4B)
Stock Price: $0.33 (¥52)
Exchange Rate: 1 USD = ¥158.23

Notice of Completion of Payment for the Issuance of the 41st Stock Acquisition Rights (with Exercise Price Adjustment Clause) and the 42nd Stock Acquisition Rights by Third-Party Allotment

The 41st stock acquisition rights and the 42nd stock acquisition rights (allocated to Mr. Ryo Kubota) were issued by third-party allotment, and total payments amounted to 1,800,000 yen. The 41st rights include provisions for floor and ceiling exercise prices, price calculation by adjustment date, and treatment of shareholder record dates. The 42nd rights include full allocation and a full ratchet provision; payment total was 1,200,200,000 yen. Exercise periods are from 2026-11-10 to 2028-11-10 and from 2026-11-10 to 2031-11-10, respectively.

Importance:
Page Updated: November 9, 2026
IR Disclosure Date: November 9, 2026

Key Figures

  • Total issuance amount for the 41st stock acquisition rights: 1,600,000 yen
  • Total issuance amount for the 42nd stock acquisition rights: 200,000 yen
  • Total exercise price amount for the 41st stock acquisition rights: 1,200,000,000 yen
  • Number of potentially dilutive shares from the 41st stock acquisition rights: 20,000,000 shares
  • Number of potentially dilutive shares from the 42nd stock acquisition rights: 20,000,000 shares
  • Exercise period 41st: 2026/11/10〜2028/11/10
  • Exercise period 42nd: 2026/11/10〜2031/11/10

AI要約

Issuance of Stock Acquisition Rights and Completion of Payment

Kubota Pharmaceutical Holdings Co., Ltd. announced the completion of payment on 2026-11-09 for the issuance by third-party allotment of the 41st stock acquisition rights (with exercise price adjustment clause) and the 42nd stock acquisition rights. The 41st stock acquisition rights consist of 200,000 units with a total issuance amount of 1,600,000 yen; the number of potentially dilutive shares is 20,000,000 shares, the floor exercise price is 30 yen, and there is no ceiling. The 42nd stock acquisition rights consist of 200,000 units with a total issuance amount of 200,000 yen; the number of potentially dilutive shares is 20,000,000 shares, the exercise price is 60 yen, and they include a full ratchet provision. The total payment amounts are reported as 1,201,600,000 yen and 1,200,200,000 yen, respectively.

Exercise Periods and Special Provisions

The exercise period for the 41st stock acquisition rights is from 2026-11-10 to 2028-11-10, and for the 42nd stock acquisition rights from 2026-11-10 to 2031-11-10. The 41st rights include conditions for adjustment of the exercise price, with detailed adjustment rules for periods such as shareholder record dates. The 42nd rights may be partially adjusted pursuant to a purchase agreement concluded with Mr. Ryo Kubota, and include conditions such as the approval of the Audit and Supervisory Committee.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Kubota Pharmaceutical Holdings Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →